Overview
Nordic care firm's Q4 revenue beat analyst expectations despite a slight yr/yr decline
Q4 EBITA rose significantly, beating analyst estimates
Company updated financial target to achieve adjusted EPS of at least SEK 9 by 2028
Outlook
Attendo targets adjusted EPS of at least SEK 9 by 2028
Company plans 800 new beds to expand capacity
Result Drivers
HIGHER OCCUPANCY - Attendo reported increased occupancy in its homes, reaching 88% compared to 85% in the previous year
STAFFING PLANNING - Improved staffing planning contributed to Attendo's positive results for the quarter
EXPANSION PLANS - Attendo plans to add 800 new beds to meet growing care needs, as stated by CEO Martin Tivéus
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Beat
SEK 4.80 bln
SEK 4.75 bln (4 Analysts)
Q4 Adjusted EPS
SEK 1.65
Q4 EPS
SEK 1.75
Q4 Net Income
SEK 259 mln
Q4 EBITA
Beat
SEK 494 mln
SEK 429.05 mln (4 Analysts)
Q4 Free Cash Flow
SEK 482 mln
Q4 Organic Growth
0.10%
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Attendo AB (publ) is SEK97.50, about 7.5% above its February 4 closing price of SEK90.70
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago
Press Release: ID:nMFN288NbD
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)